Biotech Values

[turtlepower]

Qnexa is dead in the water

I agree with you though this tidbit from a reuters article seems interesting.

Their decision stunned investors, who had more than doubled the share price of the California biotech in the last year on hopes that safety woes would not keep the drug from market.

An FDA official was also surprised.

"When you listen to even the no votes, you got the sense that a lot of people, they weren't strongly against the drug," said Eric Colman, deputy director of FDA's division that oversees such drugs.

http://www.reuters.com/article/idCNN1520175720100715